Zobrazeno 1 - 10
of 205
pro vyhledávání: '"Sanjuan-Pla A"'
Autor:
C. Garcia-Ruiz, C. Martínez-Valiente, A. Liquori, A. Gutiérrez-Adán, J. Cervera, A. Sanjuan-Pla
Publikováno v:
HemaSphere, Vol 6, Pp 62-63 (2022)
Externí odkaz:
https://doaj.org/article/eca29fbabed84e10891d6bd1d6779338
Autor:
Anna Vidal-Crespo, Alba Matas-Céspedes, Vanina Rodriguez, Cédric Rossi, Juan G. Valero, Neus Serrat, Alejandra Sanjuan-Pla, Pablo Menéndez, Gaël Roué, Armando López-Guillermo, Eva Giné, Elías Campo, Dolors Colomer, Christine Bezombes, Jeroen Lammerts van Bueren, Christopher Chiu, Parul Doshi, Patricia Pérez-Galán
Publikováno v:
Haematologica, Vol 105, Iss 4 (2020)
CD38 is expressed in several types of non-Hodgkin lymphoma (NHL) and constitutes a promising target for antibody-based therapy. Daratumumab (Darzalex) is a first-in-class anti-CD38 antibody approved for the treatment of relapsed/refractory (R/R) mult
Externí odkaz:
https://doaj.org/article/399f5cef53eb41f6a8c559013f6c32d8
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Cristina Martínez-Valiente, Cristian Garcia-Ruiz, Beatriz Rosón, Alessandro Liquori, Elisa González-Romero, Raúl Fernández-González, Isabel Gómez-Redondo, José Cervera, Alfonso Gutiérrez-Adán, Alejandra Sanjuan-Pla
Publikováno v:
International Journal of Molecular Sciences, Vol 22, Iss 13, p 6963 (2021)
Mutations in splicing factors are recurrent somatic alterations identified in myelodysplastic syndromes (MDS) and they frequently coincide with mutations in epigenetic factors. About 25% of patients present concurrent mutations in such pathways, sugg
Externí odkaz:
https://doaj.org/article/89652a033e3e4434897a2e72074b1399
Autor:
Elisa González-Romero, Cristina Martínez-Valiente, Cristian García-Ruiz, Rafael P. Vázquez-Manrique, José Cervera, Alejandra Sanjuan-Pla
Publikováno v:
Haematologica, Vol 104, Iss 5 (2019)
Advances in genome engineering in the last decade, particularly in the development of programmable nucleases, have made it possible to edit the genomes of most cell types precisely and efficiently. Chief among these advances, the clustered regularly
Externí odkaz:
https://doaj.org/article/02a4545fe77d417db95296ef2230dddd
Autor:
Clara Recasens-Zorzo, Teresa Cardesa-Salzmann, Paolo Petazzi, Laia Ros-Blanco, Anna Esteve-Arenys, Guillem Clot, Martina Guerrero-Hernández, Vanina Rodríguez, Davide Soldini, Alexandra Valera, Alexandra Moros, Fina Climent, Eva González-Barca, Santiago Mercadal, Leonor Arenillas, Xavier Calvo, José Luís Mate, Gonzalo Gutiérrez-García, Isolda Casanova, Ramón Mangues, Alejandra Sanjuan-Pla, Clara Bueno, Pablo Menéndez, Antonio Martínez, Dolors Colomer, Roger Estrada Tejedor, Jordi Teixidó, Elias Campo, Armando López-Guillermo, José Ignacio Borrell, Luis Colomo, Patricia Pérez-Galán, Gaël Roué
Publikováno v:
Haematologica, Vol 104, Iss 4 (2019)
Constitutive activation of the chemokine receptor CXCR4 has been associated with tumor progression, invasion, and chemotherapy resistance in different cancer subtypes. Although the CXCR4 pathway has recently been suggested as an adverse prognostic ma
Externí odkaz:
https://doaj.org/article/88843c89d42f42cebc3782239583b7fd
Autor:
Cristian Garcia-Ruiz, Cristina Martínez-Valiente, Lourdes Cordón, Alessandro Liquori, Raúl Fernández-González, Eva Pericuesta, Juan Sandoval, José Cervera, Alfonso Gutiérrez-Adán, Alejandra Sanjuan-Pla
Publikováno v:
Leukemia
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
10 Pág.
RNA splicing and epigenetic gene mutations are the most frequent genetic lesions found in patients with myelodysplastic neoplasm (MDS). About 25% of patients present concomitant mutations in such pathways, suggesting a cooperative role
RNA splicing and epigenetic gene mutations are the most frequent genetic lesions found in patients with myelodysplastic neoplasm (MDS). About 25% of patients present concomitant mutations in such pathways, suggesting a cooperative role
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5dad27d00460c0c3bfe16c2e0cb6e26b
https://api.elsevier.com/content/abstract/scopus_id/85136934199
https://api.elsevier.com/content/abstract/scopus_id/85136934199
Autor:
Sanjuan-Pla, Alejandra *, Bueno, Clara, Prieto, Cristina, Acha, Pamela, Stam, Ronald W., Marschalek, Rolf, Menéndez, Pablo *
Publikováno v:
In Blood 17 December 2015 126(25):2676-2685
Autor:
Amit Grover, Alejandra Sanjuan-Pla, Supat Thongjuea, Joana Carrelha, Alice Giustacchini, Adriana Gambardella, Iain Macaulay, Elena Mancini, Tiago C. Luis, Adam Mead, Sten Eirik W. Jacobsen, Claus Nerlov
Publikováno v:
Nature Communications, Vol 7, Iss 1, Pp 1-12 (2016)
With age, haematopoietic stem cells (HSCs) produce more myeloid than lymphoid cells, affecting adaptive immunity. By combining HSC single cell transcriptomics with functional studies, Grover et al. find that platelet production is also increased in o
Externí odkaz:
https://doaj.org/article/81c978c8b4c243cab74583942727f9f7
Autor:
Katrin Ottersbach, Alejandra Sanjuan-Pla, Raúl Torres-Ruíz, Clara Bueno, Talia Velasco-Hernández, Pablo Menendez
Publikováno v:
HemaSphere, Vol 2, Iss 4 (2018)
Externí odkaz:
https://doaj.org/article/9c92e7963b0a412c83ccbc1c1254af41